Listed Companies > Listed Companies Info. > Main Board Companies > Listed Company Profile
General Stock Board Listed Company Profile
Code:
Industry:
Local/Foreign Company:
8279 SYNGEN
中文
Company Profile
Chairman CEO Spokesperson Tel Address Date of Listing (Regular)
Chen, Wei-Jen Chen, Wei-Jen Jesse Wu (06)6323588 Building A, NO.154,Kai-Yuan Road,Hsin-Ying(730), Tainan, Taiwan 2016/09/26
Industry Main Business
Biotechnology and Medical Care
SYNGEN BIOTECH Founded in April 1999, Syngen Biotech Co., Ltd is a fast-growing biotech company which specialized in strain identification, micro-organism fermentation, recovery and purification to improve people’s lives by providing the best quality of products such as active pharmaceutical ingredients, nutritional ingredients, biology fermentation products, biology agriculture and aquaculture products. We strive to become a top tier global active pharmaceutical ingredient (APIs) manufacturer and an excellent supplier of dietary supplement in Taiwan.
 
Market Information ( 2019/12/10 )
Shr. Vol. Highest Lowest Closed Change Transaction TurnOver(%) long
margin
balance
(1,000shr.)
Short
margin
balance
(1,000shr.)
64.009 117.00  115.00  116.50  1.50  69 0.23 N/A N/A
Trading method Fun
purchase
price or
securities
pneeded
on T day
Announcement of Irregularity
(2019/12/10)
TPEx measures
adopted
(2019/12/10)
With warrants Can be shorted or margined? Detail
Normal N N N Y N Today History
 
Financial Reports
Cash Flows Items
Amount
(NT$ thousand)
Cash flows from operating activities
Cash flows from investing activities
Cash flows from financing activities
Balance
Sheets
Current assets
Non-current assets
Total assets
Current liabilities
Non-current liabilities
Total liabilities
Share capital
Capital surplus
Retained earnings
Other equity interest
Treasury shares
Total equity attributable to owners of parent
Non-controlling interests
Total equity
Book Value per share(NT$)
Comprehensive Income Operating revenue
Operating costs
Gross profit from operations
Operating expenses
Net other income (expenses)
Net operating income
Non-operating income and expenses
Profit before tax
Tax expense
Profit from continuing operations
Profit from discontinued operations
Profit
Other comprehensive income
Comprehensive income
Basic earnings per share
* Auditor's report on latest financial statements: auditor's report:
* More detail:MOPS
* Foreign issuers’ information is disclosed in consolidated statements.